SCHEMBL4686830

SCHEMBL4686830

O=C(Nc1ccccc1F)Nc1ncnc2n[nH]cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.51
RAB9A P51151 9/20 0.51
SMN1; SMN2 Q16637 7/20 0.51
HTT P42858 4/20 0.45
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 5/20 0.43
MEN1 O00255 3/20 0.43
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
AURKB Q96GD4 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42
PKM P14618 1/20 0.42
MAPT P10636 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4686972 0.85 HTT (0.48) NPC1RAB9ASMN1; SMN2HTTPOLB
SCHEMBL4693021 0.82 ADORA3 (0.60) NPC1RAB9ASMN1; SMN2HTTAURKA
SCHEMBL4686832 0.79 PTK2 (0.68) NPC1RAB9ASMN1; SMN2HTTPOLB
SCHEMBL4690818 0.76 ADORA3 (0.48) NPC1RAB9APOLBAURKARPS6KB1
SCHEMBL4691851 0.75 RAB9A (0.46) NPC1RAB9ASMN1; SMN2HTTKMT2A
SCHEMBL4686910 0.74 KMT2A (0.54) NPC1RAB9AHTTPOLBKMT2A
SCHEMBL4686837 0.72 KDM4E (0.51) SMN1; SMN2HTTL3MBTL1KMT2AMEN1
SCHEMBL11202950 0.72 RAB9A (1.00) NPC1RAB9ASMN1; SMN2HTTPOLB
SCHEMBL30851501 0.72 RAB9A (1.00) NPC1RAB9ASMN1; SMN2HTTPOLB
SCHEMBL3470637 0.67 MAPK1 (0.56) HTTAURKBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1360582-A Quinazoline derivs. ASTRAZENECA UK LTD (GB) 2002-07-24 CN claimed
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
EP-1218353-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA UK LTD (GB) 2007-10-17 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
US-6806274-B1 IMMUNOREGULATION OR IMMUNOSUPPRESSIVE AGENTS; TYROSINE KINASE INHIBITORS; PREVENTING ORGAN TRANSPLANT REJECTION; AUTOIMMUNE CONDITIONS; REDUCED SIDE EFFECTS ASTRAZENECA UK LIMITED (GB) 2004-10-19 US disclosed
CN-1360582-A Quinazoline derivs. ASTRAZENECA UK LTD (GB) 2002-07-24 CN disclosed